€4.7B Irish R&D scheme threatens move

An Irish businessman's grand plan to build the world's largest R&D hub--the ambitiously titled Global Pharmaceutical Centre of Excellence--has attracted the avid interest of the country's many newspapers. And now backers are once again in the headlines with a threat to take their project and go to the North if local economic development officials don't deliver the support they'll need. At stake, backers claim, is a €4.7 billion project that could deliver some 4,500 jobs at a time many of the major pharma companies have been scaling back in the country. Story

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.